A new research perspective was published in Oncotarget’s Volume 15 on February 5, 2024, entitled, “Preclinical and clinical evaluation of the Janus Kinase inhibitor ruxolitinib in multiple myeloma.”
New study shows dramatic health benefits of quitting smoking
People who quit smoking see major gains in life expectancy after just a few years, according to a new study by University of Toronto researchers
February 10, 2024